Angiogenesis Assays Market Snapshot (2023 to 2033)

The anticipated size of the angiogenesis assays market in 2022 was US$ 1,972.1 million and is estimated to be US$ 2,139.7 million in 2023. Increase in demand for angiogenesis assays majorly used in academic institutions and biotech companies is also contributing to the growth of this market. Future Market Insights has mentioned in its reports that the automotive composites market will expand at a CAGR of 9.10% between 2023 and 2033, totaling around US$ 5,112.2 million by 2033.

Angiogenesis is the process of the formation of new blood vessels from pre-existing vasculature where it involves the proliferation, migration, and differentiation of endothelial cells which leads to increased vascularization because this process is physiologically important for the development and wound healing and is also a common driver in multiple diseases including rheumatoid arthritis, atherosclerosis, macular degeneration, and cancer.

North America is considered to be a dominant region for the Angiogenesis Assay Market, owing to the increase in diseases such as tumor formulations, diabetic retinopathy, obesity, and metastasis.

Attribute Details
Projected Forecast Value (2022) US$ 1,972.1 million
Projected Forecast Value (2023) US$ 2,139.7 million
Projected Forecast Value (2033) US$ 5,112.2 million
Growth rate 9.10% CAGR
Forecast period 2023 to 2033

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Angiogenesis Assays Market Historical Analysis (2017 to 2022) Vs. Forecast Outlook (2023 to 2033)

The global angiogenesis assays market grew at a CAGR of 7.3% between 2017 and 2022. Growth forecasts remain optimistic, with the market predicted to exhibit a CAGR of 9.1% between 2023 and 2033.

Angiogenesis occurs in response to a variety of molecular cues as generally, the angiogenic process includes endothelial cell proliferation, chemotactic endothelial cell migration through the extracellular matrix barrier, and the formation of capillary tubes. Physiological and pathological angiogenesis utilize many of the same cellular processes and molecular signaling networks, however, the structures that form during pathological angiogenesis are often functionally abnormal.

Major factor that is expected to augment the growth of the angiogenesis assay market during the forecast period includes the increasing number of research and development activities in this field. Factor that is expected to hinder the growth of the angiogenesis assay market during the forecast period includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays

Which are Some Prominent Drivers Spearheading Angiogenesis Assay Market Growth?

Increase in the Number of Research and Development Activities

Major factor that is expected to drive the growth of the angiogenesis assay market during the forecast period includes an increasing number of research and development activities in this field. Rising Research and Development spending on cancer therapeutics is another major factor that is expected to fuel market growth.

Rise in Medical Tourism in Different Regions

Other factors that are anticipated to accelerate the growth of the angiogenesis assay market during the forecast period include increasing medical tourism in some regions. Factors such as the availability of government initiatives supporting research activities and product development are also favoring market growth.

Sabyasachi Ghosh
Sabyasachi Ghosh

Principal Consultant

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

What are the Challenges Faced by the Angiogenesis Assay Industry?

Biochemical Analysis of the Molecular Events

Major factor that is expected to hamper the growth of the angiogenesis assay market during the forecast period includes scaling up this technique, which tends to make a biochemical analysis of the molecular events mediating wound repair difficult.

Lack of Angiogenesis’ Accurate Analysis

Challenge that hinders market growth includes the lack of angiogenesis’ accurate analysis of highly varied results achieved from many angiogenesis assays currently in use.

Region-wise Analysis

How is North America Emerging as an Opportunistic Angiogenesis Assay Market?

Increase in Developed Infrastructure, High Spending Capacity as well as Strict Regulations

North America holds the major share of the market, attributed to the developed infrastructure, high spending capacity as well as strict regulations in the angiogenesis assay market with a market share of 38.1%

United States factor expected to accelerate the market growth in the region includes the increase in diseases such as tumor formulations, diabetic retinopathy, obesity, and metastasis with a market share of 43.0%. North American angiogenesis assay market is expected to expand at an 8% CAGR during the forecast period

How is Asia Pacific Contributing to the Growth of the Angiogenesis Assay Market?

Rise in Investments from the Manufacturers

Future Market Insights says that Asia Pacific is anticipated to witness growth at a lucrative rate over the forecast period, owing to the increased investments from the manufacturers.

Asia Pacific countries including India are said to grow at a CAGR of 10.9% and China’s growth at a CAGR of 10.2% is anticipated to favor the growth of the angiogenesis assay market during the forecast period, attributed to the rising prevalence of the chronic diseases, and increasing cell-based studies in the region including Australia growing at a CAGR of 8.7% and Japan holding the value share of 5.3%.

Why is the European Market for Angiogenesis Assay Market said to be Rising?

Boost the Focus of Research and Regenerative Medicine for the Market

Europe is said to hold a market share of 29.3% after North America, where the United Kingdom and Germany are said to hold a major portion in this market where United Kingdom grows at a CAGR of 8.1% whereas Germany has a value share of 6.7%

Get the data you need at a Fraction of the cost

Personalize your report by choosing insights you need
and save 40%!

Category-wise Analysis

Which Product is said to have a Dominant Position in the Market?

Angiogenesis Tube Formation Assays are said to Hold a Dominant Position

Angiogenesis tube formation assays are said to hold a major market share of 52.3% where new blood vessels will be formed from pre-existing vessels. Angiogenesis plays an important role in physiological and pathological conditions like wound healing, embryonic development, cancer growth, etc.

Which Application is said to be Faring?

In-vitro Angiogenesis Application is Said to be Faring

In-vitro application angiogenesis holds a market share of 63.0% as the device is used in the measurement of protein or any other substance present in biological fluids and tissues, like blood, urine, serum, or tissue.

Which End-User is Said to be the Most in Demand?

Hospitals are considered to be the Most in Demand

Hospitals hold a value share of 48.0% in this market as the treatment for angiogenesis assays can be taken with proper care in hospitals itself.

Competitive Analysis

Some of the prominent players in the global market are-

  • Cell Biolabs, Inc.
  • Thermo Fisher Scientific
  • Abcam plc.
  • PromoCell GmbH
  • Merck KGaA
  • ATCC
  • Corning Incorporated
  • Bio-Techne
  • Molecular Devices, LLC
  • BioVision, Inc

Some of the important developments of the key players in the market are:

  • In May 2023, A new associate clinical research associate (ACRA) professional development program at Merck, known as MSD outside the United States and Canada, aims to increase and diversify the clinical research workforce. The program welcomes and trains new employees who do not have a CRA background but have transferable skills.
  • In April 2023, BioVisionCenter (BVC) is a recently launched new research center situated at the Irchel campus of the University of Zurich (UZH). Its mission is to become a worldwide leading research center for the promotion of comprehensive, scientific bioimage data exploration. Besides developing and implementing new technologies, the BVC will provide a computational platform as a service to its users that enables scalable bioimage analysis across multiple modalities and scales, from cryo-EM to whole organ imaging.

Scope of Report

Attribute Details
Growth Rate CAGR of 9.10% from 2023 to 2033
Market value in 2023 US$ 2,139.7 million
Market value in 2033 US$ 5,112.2 million
Base Year for Estimation 2022
Historical Data 2017 to 2022
Forecast Period 2023 to 2033
Quantitative Units US$ million for Value and CAGR from 2023 to 2033
Report Coverage Revenue Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered By Product Type, By Application, By End-user, By Region
Regions Covered North America; Latin America; Western Europe; Eastern Europe; South Asia and Pacific; East Asia; Middle East & Africa
Key Countries Profiled United States, Canada, Brazil, Mexico, Germany, United Kingdom, France, Spain, Italy, Poland, Russia, Czech Republic, Romania, India, Bangladesh, Australia, New Zealand, China, Japan, South Korea, GCC Countries, South Africa, Israel, Rest of MEA
Key Companies Profiled Cell Biolabs, Inc.; Thermo Fisher Scientific; Abcam plc.; PromoCell GmbH; Merck KGaA; ATCC; Corning Incorporated; Bio-Techne; Molecular Devices, LLC; BioVision, Inc
Customisation Scope Available on Request

Key Segments Profiled in the Angiogenesis Assay Industry Survey

By Product Type:

  • Angiogenesis Tube Formation Assays
  • Microfluidic
  • Endothelial Adhesion
  • Invasion and Migration Assays

By Application:

  • In Vitro Angiogenesis
  • In Vivo Angiogenesis

By End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers

By Region:

  • North America
  • Latin America
  • Western Europe
  • Eastern Europe
  • Asia Pacific excluding Japan
  • China
  • Japan
  • Middle East & Africa

Frequently Asked Questions

What is the Market Value in 2023? 

The market is valued at US$ 2.1 billion in 2023. 

What is the CAGR from 2023 to 2033? 

The market’s CAGR from 2023 to 2033 will be 9.1%. 

Who are the Key Market Players? 

Cell Biolabs, Inc., Thermo Fisher Scientific, and Abcam plc are the key market players. 

How was the Historical Performance of the Market? 

The market captured a CAGR of 7.3% from 2017 to 2022.

What is the Estimated Market Size in 2033? 

The market is estimated to reach US$ 5.1 billion by 2033. 

Table of Content
1. Executive Summary
    1.1. Global Market Outlook
    1.2. Demand-side Trends
    1.3. Supply-side Trends
    1.4. Technology Roadmap Analysis
    1.5. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Background
    3.1. Market Dynamics
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity
        3.1.4. Trends
    3.2. Scenario Forecast
        3.2.1. Demand in Optimistic Scenario
        3.2.2. Demand in Likely Scenario
        3.2.3. Demand in Conservative Scenario
    3.3. Opportunity Map Analysis
    3.4. Investment Feasibility Matrix
    3.5. PESTLE and Porter’s Analysis
    3.6. Regulatory Landscape
        3.6.1. By Key Regions
        3.6.2. By Key Countries
    3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2022 and Forecast, 2023 to 2033
    4.1. Historical Market Size Value (US$ Million) Analysis, 2017 to 2022
    4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Product Type
    5.1. Introduction / Key Findings
    5.2. Historical Market Size Value (US$ Million) Analysis By Product Type, 2017 to 2022
    5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Product Type, 2023 to 2033
        5.3.1. Angiogenesis Tube Formation Assays
        5.3.2. Microfluidic
        5.3.3. Endothelial Adhesion
        5.3.4. Invasion and Migration Assays
    5.4. Y-o-Y Growth Trend Analysis By Product Type, 2017 to 2022
    5.5. Absolute $ Opportunity Analysis By Product Type, 2023 to 2033
6. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Application
    6.1. Introduction / Key Findings
    6.2. Historical Market Size Value (US$ Million) Analysis By Application, 2017 to 2022
    6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033
        6.3.1. In Vitro Angiogenesis
        6.3.2. In Vivo Angiogenesis
    6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2022
    6.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033
7. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By User
    7.1. Introduction / Key Findings
    7.2. Historical Market Size Value (US$ Million) Analysis by User, 2017 to 2022
    7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast by User, 2023 to 2033
        7.3.1. Hospitals
        7.3.2. Specialty Clinics
        7.3.3. Ambulatory Surgical Centers
    7.4. Y-o-Y Growth Trend Analysis by User, 2017 to 2022
    7.5. Absolute $ Opportunity Analysis by User, 2023 to 2033
8. Global Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Region
    8.1. Introduction
    8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2017 to 2022
    8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033
        8.3.1. North America
        8.3.2. Latin America
        8.3.3. Western Europe
        8.3.4. Eastern Europe
        8.3.5. South Asia and Pacific
        8.3.6. East Asia
        8.3.7. Middle East and Africa
    8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        9.2.1. By Country
            9.2.1.1. The USA
            9.2.1.2. Canada
        9.2.2. By Product Type
        9.2.3. By Application
        9.2.4. By User
    9.3. Market Attractiveness Analysis
        9.3.1. By Country
        9.3.2. By Product Type
        9.3.3. By Application
        9.3.4. By User
    9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        10.2.1. By Country
            10.2.1.1. Brazil
            10.2.1.2. Mexico
            10.2.1.3. Rest of Latin America
        10.2.2. By Product Type
        10.2.3. By Application
        10.2.4. By User
    10.3. Market Attractiveness Analysis
        10.3.1. By Country
        10.3.2. By Product Type
        10.3.3. By Application
        10.3.4. By User
    10.4. Key Takeaways
11. Western Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        11.2.1. By Country
            11.2.1.1. Germany
            11.2.1.2. United Kingdom
            11.2.1.3. France
            11.2.1.4. Spain
            11.2.1.5. Italy
            11.2.1.6. Rest of Western Europe
        11.2.2. By Product Type
        11.2.3. By Application
        11.2.4. By User
    11.3. Market Attractiveness Analysis
        11.3.1. By Country
        11.3.2. By Product Type
        11.3.3. By Application
        11.3.4. By User
    11.4. Key Takeaways
12. Eastern Europe Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        12.2.1. By Country
            12.2.1.1. Poland
            12.2.1.2. Russia
            12.2.1.3. Czech Republic
            12.2.1.4. Romania
            12.2.1.5. Rest of Eastern Europe
        12.2.2. By Product Type
        12.2.3. By Application
        12.2.4. By User
    12.3. Market Attractiveness Analysis
        12.3.1. By Country
        12.3.2. By Product Type
        12.3.3. By Application
        12.3.4. By User
    12.4. Key Takeaways
13. South Asia and Pacific Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        13.2.1. By Country
            13.2.1.1. India
            13.2.1.2. Bangladesh
            13.2.1.3. Australia
            13.2.1.4. New Zealand
            13.2.1.5. Rest of South Asia and Pacific
        13.2.2. By Product Type
        13.2.3. By Application
        13.2.4. By User
    13.3. Market Attractiveness Analysis
        13.3.1. By Country
        13.3.2. By Product Type
        13.3.3. By Application
        13.3.4. By User
    13.4. Key Takeaways
14. East Asia Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        14.2.1. By Country
            14.2.1.1. China
            14.2.1.2. Japan
            14.2.1.3. South Korea
        14.2.2. By Product Type
        14.2.3. By Application
        14.2.4. By User
    14.3. Market Attractiveness Analysis
        14.3.1. By Country
        14.3.2. By Product Type
        14.3.3. By Application
        14.3.4. By User
    14.4. Key Takeaways
15. Middle East and Africa Market Analysis 2017 to 2022 and Forecast 2023 to 2033, By Country
    15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2017 to 2022
    15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033
        15.2.1. By Country
            15.2.1.1. GCC Countries
            15.2.1.2. South Africa
            15.2.1.3. Israel
            15.2.1.4. Rest of MEA
        15.2.2. By Product Type
        15.2.3. By Application
        15.2.4. By User
    15.3. Market Attractiveness Analysis
        15.3.1. By Country
        15.3.2. By Product Type
        15.3.3. By Application
        15.3.4. By User
    15.4. Key Takeaways
16. Key Countries Market Analysis
    16.1. USA
        16.1.1. Pricing Analysis
        16.1.2. Market Share Analysis, 2022
            16.1.2.1. By Product Type
            16.1.2.2. By Application
            16.1.2.3. By User
    16.2. Canada
        16.2.1. Pricing Analysis
        16.2.2. Market Share Analysis, 2022
            16.2.2.1. By Product Type
            16.2.2.2. By Application
            16.2.2.3. By User
    16.3. Brazil
        16.3.1. Pricing Analysis
        16.3.2. Market Share Analysis, 2022
            16.3.2.1. By Product Type
            16.3.2.2. By Application
            16.3.2.3. By User
    16.4. Mexico
        16.4.1. Pricing Analysis
        16.4.2. Market Share Analysis, 2022
            16.4.2.1. By Product Type
            16.4.2.2. By Application
            16.4.2.3. By User
    16.5. Germany
        16.5.1. Pricing Analysis
        16.5.2. Market Share Analysis, 2022
            16.5.2.1. By Product Type
            16.5.2.2. By Application
            16.5.2.3. By User
    16.6. United Kingdom
        16.6.1. Pricing Analysis
        16.6.2. Market Share Analysis, 2022
            16.6.2.1. By Product Type
            16.6.2.2. By Application
            16.6.2.3. By User
    16.7. France
        16.7.1. Pricing Analysis
        16.7.2. Market Share Analysis, 2022
            16.7.2.1. By Product Type
            16.7.2.2. By Application
            16.7.2.3. By User
    16.8. Spain
        16.8.1. Pricing Analysis
        16.8.2. Market Share Analysis, 2022
            16.8.2.1. By Product Type
            16.8.2.2. By Application
            16.8.2.3. By User
    16.9. Italy
        16.9.1. Pricing Analysis
        16.9.2. Market Share Analysis, 2022
            16.9.2.1. By Product Type
            16.9.2.2. By Application
            16.9.2.3. By User
    16.10. Poland
        16.10.1. Pricing Analysis
        16.10.2. Market Share Analysis, 2022
            16.10.2.1. By Product Type
            16.10.2.2. By Application
            16.10.2.3. By User
    16.11. Russia
        16.11.1. Pricing Analysis
        16.11.2. Market Share Analysis, 2022
            16.11.2.1. By Product Type
            16.11.2.2. By Application
            16.11.2.3. By User
    16.12. Czech Republic
        16.12.1. Pricing Analysis
        16.12.2. Market Share Analysis, 2022
            16.12.2.1. By Product Type
            16.12.2.2. By Application
            16.12.2.3. By User
    16.13. Romania
        16.13.1. Pricing Analysis
        16.13.2. Market Share Analysis, 2022
            16.13.2.1. By Product Type
            16.13.2.2. By Application
            16.13.2.3. By User
    16.14. India
        16.14.1. Pricing Analysis
        16.14.2. Market Share Analysis, 2022
            16.14.2.1. By Product Type
            16.14.2.2. By Application
            16.14.2.3. By User
    16.15. Bangladesh
        16.15.1. Pricing Analysis
        16.15.2. Market Share Analysis, 2022
            16.15.2.1. By Product Type
            16.15.2.2. By Application
            16.15.2.3. By User
    16.16. Australia
        16.16.1. Pricing Analysis
        16.16.2. Market Share Analysis, 2022
            16.16.2.1. By Product Type
            16.16.2.2. By Application
            16.16.2.3. By User
    16.17. New Zealand
        16.17.1. Pricing Analysis
        16.17.2. Market Share Analysis, 2022
            16.17.2.1. By Product Type
            16.17.2.2. By Application
            16.17.2.3. By User
    16.18. China
        16.18.1. Pricing Analysis
        16.18.2. Market Share Analysis, 2022
            16.18.2.1. By Product Type
            16.18.2.2. By Application
            16.18.2.3. By User
    16.19. Japan
        16.19.1. Pricing Analysis
        16.19.2. Market Share Analysis, 2022
            16.19.2.1. By Product Type
            16.19.2.2. By Application
            16.19.2.3. By User
    16.20. South Korea
        16.20.1. Pricing Analysis
        16.20.2. Market Share Analysis, 2022
            16.20.2.1. By Product Type
            16.20.2.2. By Application
            16.20.2.3. By User
    16.21. GCC Countries
        16.21.1. Pricing Analysis
        16.21.2. Market Share Analysis, 2022
            16.21.2.1. By Product Type
            16.21.2.2. By Application
            16.21.2.3. By User
    16.22. South Africa
        16.22.1. Pricing Analysis
        16.22.2. Market Share Analysis, 2022
            16.22.2.1. By Product Type
            16.22.2.2. By Application
            16.22.2.3. By User
    16.23. Israel
        16.23.1. Pricing Analysis
        16.23.2. Market Share Analysis, 2022
            16.23.2.1. By Product Type
            16.23.2.2. By Application
            16.23.2.3. By User
17. Market Structure Analysis
    17.1. Competition Dashboard
    17.2. Competition Benchmarking
    17.3. Market Share Analysis of Top Players
        17.3.1. By Regional
        17.3.2. By Product Type
        17.3.3. By Application
        17.3.4. By User
18. Competition Analysis
    18.1. Competition Deep Dive
        18.1.1. Cell Biolabs, Inc.
            18.1.1.1. Overview
            18.1.1.2. Product Portfolio
            18.1.1.3. Profitability by Market Segments
            18.1.1.4. Sales Footprint
            18.1.1.5. Strategy Overview
                18.1.1.5.1. Marketing Strategy
        18.1.2. Thermo Fisher Scientific
            18.1.2.1. Overview
            18.1.2.2. Product Portfolio
            18.1.2.3. Profitability by Market Segments
            18.1.2.4. Sales Footprint
            18.1.2.5. Strategy Overview
                18.1.2.5.1. Marketing Strategy
        18.1.3. Abcam plc.
            18.1.3.1. Overview
            18.1.3.2. Product Portfolio
            18.1.3.3. Profitability by Market Segments
            18.1.3.4. Sales Footprint
            18.1.3.5. Strategy Overview
                18.1.3.5.1. Marketing Strategy
        18.1.4. PromoCell GmbH
            18.1.4.1. Overview
            18.1.4.2. Product Portfolio
            18.1.4.3. Profitability by Market Segments
            18.1.4.4. Sales Footprint
            18.1.4.5. Strategy Overview
                18.1.4.5.1. Marketing Strategy
        18.1.5. Merck KGaA
            18.1.5.1. Overview
            18.1.5.2. Product Portfolio
            18.1.5.3. Profitability by Market Segments
            18.1.5.4. Sales Footprint
            18.1.5.5. Strategy Overview
                18.1.5.5.1. Marketing Strategy
        18.1.6. ATCC
            18.1.6.1. Overview
            18.1.6.2. Product Portfolio
            18.1.6.3. Profitability by Market Segments
            18.1.6.4. Sales Footprint
            18.1.6.5. Strategy Overview
                18.1.6.5.1. Marketing Strategy
        18.1.7. Corning Incorporated
            18.1.7.1. Overview
            18.1.7.2. Product Portfolio
            18.1.7.3. Profitability by Market Segments
            18.1.7.4. Sales Footprint
            18.1.7.5. Strategy Overview
                18.1.7.5.1. Marketing Strategy
        18.1.8. Bio-Techne
            18.1.8.1. Overview
            18.1.8.2. Product Portfolio
            18.1.8.3. Profitability by Market Segments
            18.1.8.4. Sales Footprint
            18.1.8.5. Strategy Overview
                18.1.8.5.1. Marketing Strategy
        18.1.9. Molecular Devices, LLC
            18.1.9.1. Overview
            18.1.9.2. Product Portfolio
            18.1.9.3. Profitability by Market Segments
            18.1.9.4. Sales Footprint
            18.1.9.5. Strategy Overview
                18.1.9.5.1. Marketing Strategy
        18.1.10. BioVision, Inc
            18.1.10.1. Overview
            18.1.10.2. Product Portfolio
            18.1.10.3. Profitability by Market Segments
            18.1.10.4. Sales Footprint
            18.1.10.5. Strategy Overview
                18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used
20. Research Methodology
Recommendations

Healthcare

Luciferase Assay Market

April 2024

REP-GB-5565

324 pages

Healthcare

Lateral Flow Assays Market

August 2023

REP-GB-14271

325 pages

Healthcare

Cytotoxicity Assays Market

March 2022

REP-GB-10024

250 pages

Explore Healthcare Insights

View Reports
Future Market Insights

Angiogenesis Assays Market

Schedule a Call